PUNE, India, October 29, 2015 /PRNewswire/ --
ReportsnReports.com adds "Investigation Report on China Budesonide Market, 2010-2019" and "Global and Chinese Budesonide (CAS 51333-22-3) Industry, 2015 Market Research Report" with 2019 and 2020 forecasts data and information to its online business intelligence library.
Complete report on China budesonide market spread across 30 pages, profiling 5 companies and supported with 19 charts is now available at http://www.reportsnreports.com/reports/402267-investigation-report-on-china-budesonide-market-2010-2019.html .
With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma, more so in industrialized countries and regions where tobacco consumption is high. 5% of adults and 20% of children there have been attacked by this disease and many of them come down with bronchial asthma induced by chronic cough.
Nearly 300 million people in China contract respiratory ailments, among which over 50 million suffer from cough with an annual growth rate of 4% and 15Budesonide20 million asthma. Budesonide, an adrenocortical hormone, was developed by Astrazeneca in the 1990s. It is mainly used for the treatment of non-Budesonide glucocorticoid dependent or glucocorticoid Budesonide dependent bronchial asthma and chronic obstructive pulmonary disease (COPD). In Jun. 1997, Budesonide aerosol got FDA's approval. In recent years, with the steady growth of global demand, Budesonide has occupied an important position in the TOP10 respiratory drugs.
In 1994, China approved the import of Budesonide for clinical purposes. After being marketed by Astra (Wuxi) in China in 1995, Budesonide develops fast with annual sales rising from CNY 60 million in 2005 to CNY 595 million in 2014 and CAGR reaching up to 29% during the period of 2005Budesonide2014. Budesonide enjoys a vast demand in China. Currently, Budesonide in the Chinese market mainly come from the following companies: Lunan Better Pharmaceutical Co., Ltd, Orion Corporation (Finland), WELLCOME AUSTRALIA LTD.(AU), SYNMOSA BIOPHARMA CORPORATION (TW) and Astra AB (Sweden). While they all take up certain shares in the market, WELLCOME AUSTRALIA LTD. (AU) has the largest market share of 88% with sales value reaching up to CNY 524 million in 2014. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=402267 .
The market size of Budesonide in China is expected to keep growing in the next few years. Readers of this report can get information on Budesonide market size of China, Budesonide market share of manufacturers in China, price of Budesonide in Chinese market, major manufacturers of Budesonide in Chinese market and overall Budesonide market outlook in China. Budesonide manufacturers of cortin drugs as well as investors/ research institutions interested in Chinese medicine market are suggested to buy a copy of this report.
Explore other new reports on Pharmaceuticals at http://www.reportsnreports.com/market-research/pharmaceuticals/ .
Another research titled Global and Chinese Budesonide (CAS 51333-22-3) Industry, 2015 Market Research Report is a professional and in-depth study on the current state of the global Budesonide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Budesonide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Budesonide industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Budesonide industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Budesonide Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Budesonide industry covering all important parameters. Comprehensive table of contents and more on this report is available at http://www.reportsnreports.com/reports/414316-global-and-chinese-budesonide-cas-51333-22-3-industry-2015-market-research-report.html .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Connect With Us on:
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441